Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...
KIRKLAND, QC, Sept. 19, 2024 /CNW/ - Today, Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory Syncytial Virus (RSV) in ...
Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...
Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...
For older adults, this means that RSV isn’t just another respiratory virus, but a disease that can have severe consequences. In Asia, up to 80 per cent of older adults hospitalised with RSV ...
Older adults and newborn babies are among those most at risk, leading to serious cases of pneumonia, a high number of ...
KIRKLAND, QC, Sept. 19, 2024 /CNW/ - Today, Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory Syncytial Virus (RSV) in older ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback